# David Stokoe

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-stokoe/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,715 |
| Field | PI3K/AKT/mTOR signaling in cancer |
| h-index | 63 |
| i10-index | 102 |
| Last Known Institution | Enzo Life Sciences (United States) |
| OpenAlex ID | https://openalex.org/A5082108617 |
| ORCID iD | https://orcid.org/0000-0002-6333-5364 |
| Works | 273 |

## Researcher papers

- [Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma](https://scholariq.org/papers/phase-ii-study-of-erlotinib-plus-temozolomide-during-and-after-radiation-therapy/)

## Researcher topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Ubiquitin and proteasome pathways](https://scholariq.org/topics/ubiquitin-and-proteasome-pathways-2/)
- [Microtubule and mitosis dynamics](https://scholariq.org/topics/microtubule-and-mitosis-dynamics/)
- [Protein Kinase Regulation and GTPase Signaling](https://scholariq.org/topics/protein-kinase-regulation-and-gtpase-signaling/)

## Researcher university

- [Enzo Life Sciences (United States)](https://scholariq.org/institutions/enzo-life-sciences-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.